期刊文献+

靶向核因子E2相关因子2信号通路的抗衰老中药研究进展 被引量:1

Traditional Chinese medicine used as anti-aging agent by targeting nuclear factor erythroid 2-related factor 2 signaling pathway
原文传递
导出
摘要 机体的氧化还原稳态失衡是衰老的主要特征,也是多种衰老相关疾病的主要发病机制。作为机体氧化还原稳态的调控中枢,转录因子核因子E2相关因子2(nuclear factor erythroid 2-related factor 2, NRF2)可通过激活多种抗氧化酶的转录缓解氧化应激压力。我国是中药的发源地,也是世界中药材应用最广泛、药源最丰富的国家,从古至今,中药均在临床上广泛应用,其在抗衰老方面的应用也日渐被人们所接受。本文以NRF2信号通路为核心,总结了多种抗衰老中药与NRF2调节的相关性,并结合NRF2信号网络系统分析了中药在抗衰老过程中的共性关键机制。 The imbalance of redox homeostasis is a major characteristic of aging and contributes to the pathogenesis of various aging-related diseases.As a regulatory hub of redox homeostasis,nuclear factor erythroid 2-related factor 2(NRF2)can attenuate oxidative stress by activating the transcription of many antioxidant enzymes.China is the birthplace of traditional Chinese medicine(TCM)which has been wildly used as medicine for thousands of years.Recently,TCM as anti-aging medicine has attracted enormous attention.Focusing on the NRF2 signaling pathway,this paper summarizes the correlation between various anti-aging TCM and the NRF2 signaling,and discusses the common key mechanisms by which TCM slows the aging process by targeting the NRF2 signaling network.
作者 徐嘉怡 闫亮文 唐慎康 刘朋飞 XU Jia-Yi;YAN Liang-Wen;TANG Shen-Kang;LIU Peng-Fei(National and Local Joint Engineering Research Center for Biological Diagnosis and Treatment,Second Affiliated Hospital of Xi’an Jiaotong University,Xi’an 710004,China;Department of Oncology,Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712000,China)
出处 《生理学报》 CAS CSCD 北大核心 2023年第6期877-886,共10页 Acta Physiologica Sinica
基金 supported by Innovation Capability Support Program of Shaanxi Province(No.2023KJXX-033) Key Research and Development Program of Shaanxi Province(No.2022-LL-JB-30) Medical “Base-Clinic” Integrated Innovation Project of Xi'an Jiaotong University(No.YXJLRH2022058)。
关键词 核因子E2相关因子2 中药 抗衰老 中药单体 nuclear factor erythroid 2-related factor 2 Chinese medicine anti-aging herb monomer
  • 相关文献

参考文献1

二级参考文献3

共引文献34

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部